Does LIOTHYRONINE Cause Neoplasm malignant? 9 Reports in FDA Database
Thyroid Balance & Feminine Wellness
Thyrafemme Balance — 14 gentle ingredients for energy, mood & hormonal harmony.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Neoplasm malignant have been filed in association with LIOTHYRONINE (Liothyronine Sodium). This represents 0.3% of all adverse event reports for LIOTHYRONINE.
9
Reports of Neoplasm malignant with LIOTHYRONINE
0.3%
of all LIOTHYRONINE reports
0
Deaths
4
Hospitalizations
How Dangerous Is Neoplasm malignant From LIOTHYRONINE?
Of the 9 reports, 4 (44.4%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LIOTHYRONINE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does LIOTHYRONINE Cause?
Drug ineffective (505)
Headache (381)
Hypothyroidism (321)
Hypertension (295)
Dyspnoea (285)
Therapeutic product effect incomplete (283)
Cardiac disorder (269)
Asthma (257)
Burning sensation (257)
Gastrooesophageal reflux disease (257)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which LIOTHYRONINE Alternatives Have Lower Neoplasm malignant Risk?
LIOTHYRONINE vs LIPEGFILGRASTIM
LIOTHYRONINE vs LIPITOR
LIOTHYRONINE vs LIRAGLUTIDE
LIOTHYRONINE vs LISDEXAMFETAMINE
LIOTHYRONINE vs LISDEXAMFETAMINE DIMESYLATE